Adverse Childhood Experiences Linked to Migraine in Adolescence
TUESDAY, March 8, 2022 (HealthDay News) -- Adverse childhood experiences (ACEs) are associated with migraine onset in adolescence, according to a study published online Feb. 5 in Headache: The Journal of Head and Face Pain.
Using data from the National Longitudinal Survey of Children and Youth, Nicole G. Hammond, from the University of Ottawa in Canada, and colleagues examined whether ACEs are prospectively associated with incident health professional-diagnosed migraine and prevalence of nonmigraine frequent headache in adolescence. Children aged 0/1 year at baseline were followed by the person most knowledgeable (PMK) about them until the child reached adolescence. The PMK reported on 14 ACEs when the child was 4/5 and 6/7 years and reported on depression and anxiety symptoms in late childhood (age 8/9 years). The analyses of migraine and nonmigraine frequent headache, which were measured at age 14/15 years, included 2,058 and 1,730 children, respectively.
The researchers found that 3.4 percent of children had migraine and 11.8 percent had nonmigraine frequent headache. Overall, 55.7, 34.7, and 9.6 percent experienced no ACEs, one ACE, and two or more ACEs, respectively. Direct associations were seen between experiencing one and two or more ACEs with migraine (odds ratios, 1.71 and 2.33, respectively), but not for nonmigraine frequent headache. No indirect associations were seen for symptoms of depression and anxiety with migraine or nonmigraine frequent headache.
"The lack of a mediational effect through symptoms of depression and anxiety suggests that, on their own, internalizing symptoms do not entirely explain the ACE-migraine link, at least in adolescence," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Smaller Blood Draws for Lab Tests Reduce Need for Transfusions
FRIDAY, Oct. 13, 2023 (HealthDay News) -- Drawing smaller amounts of blood from...
FDA Approves Drug for Rare Form of ALS
WEDNESDAY, April 26, 2023 (HealthDay News) -- The U.S. Food and Drug...
Persistence of Somatic Symptoms After COVID-19 Quantified
FRIDAY, Aug. 5, 2022 (HealthDay News) -- Persistent symptoms at 90 to 150 days...
No ‘Fall Back’? Sleep Experts Argue Against Daylight Standard Time
FRIDAY, Nov. 5, 2021 (HealthDay News) -- Most folks groan when the time comes to...